首页> 美国卫生研究院文献>Scientific Reports >Predicting neurological Adverse Drug Reactions based on biological chemical and phenotypic properties of drugs using machine learning models
【2h】

Predicting neurological Adverse Drug Reactions based on biological chemical and phenotypic properties of drugs using machine learning models

机译:使用机器学习模型基于药物的生物化学和表型特性预测神经性药物不良反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Adverse drug reactions (ADRs) have become one of the primary reasons for the failure of drugs and a leading cause of deaths. Owing to the severe effects of ADRs, there is an urgent need for the generation of effective models which can accurately predict ADRs during early stages of drug development based on integration of various features of drugs. In the current study, we have focused on neurological ADRs and have used various properties of drugs that include biological properties (targets, transporters and enzymes), chemical properties (substructure fingerprints), phenotypic properties (side effects (SE) and therapeutic indications) and a combinations of the two and three levels of features. We employed relief-based feature selection technique to identify relevant properties and used machine learning approach to generated learned model systems which would predict neurological ADRs prior to preclinical testing. Additionally, in order to explain the efficiency and applicability of the models, we tested them to predict the ADRs for already existing anti-Alzheimer drugs and uncharacterized drugs, respectively in side effect resource (SIDER) database. The generated models were highly accurate and our results showed that the models based on chemical (accuracy 93.20%), phenotypic (accuracy 92.41%) and combination of three properties (accuracy 94.18%) were highly accurate while the models based on biological properties (accuracy 82.11%) were highly informative.
机译:药物不良反应(ADR)已成为药物失败和死亡的主要原因之一。由于ADR的严重影响,迫切需要一种有效的模型的生成,该模型可以基于各种药物的集成,在药物开发的早期阶段准确预测ADR。在当前的研究中,我们专注于神经系统ADR,并使用了药物的各种特性,包括生物学特性(靶标,转运蛋白和酶),化学特性(亚结构指纹),表型特性(副作用(SE)和治疗适应症)和两级和三级功能的组合。我们采用基于救济的特征选择技术来识别相关属性,并使用机器学习方法来生成学习模型系统,该模型系统会在临床前测试之前预测神经系统ADR。此外,为了解释模型的效率和适用性,我们分别在副作用资源(SIDER)数据库中对它们进行了测试,以预测已存在的抗阿尔茨海默氏病药物和未表征药物的ADR。生成的模型是高度准确的,我们的结果表明,基于化学模型(准确度为93.20%),表型(准确度为92.41%)和三种性质的组合(准确度为94.18%)的模型是高度准确的,而基于生物学性质(准确度)的模型82.11%)的信息量很高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号